Agenus
NASDAQ: AGENLexington, US · Delaware corporation · 4 known investors
BiotechHealthtechMedical Devices
Founders & leadership
TD
Tom DechaeneDirector
OB
Ozer BaysalExecutive Officer
WJ
Wadih JordanDirector
GA
Garo ArmenExecutive Officer, Director
RS
Robert SteinExecutive Officer
TW
Timothy WrightDirector
CK
Christine KlaskinExecutive Officer
SS
Shalini SharpDirector
KV
Karen ValentineExecutive Officer
BC
Brian CorveseDirector
SM
Shahzad MalikDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$30MraisedFeb 2019 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian CorveseDirector
- Evan KearnsExecutive Officer
- Timothy R. WrightDirector
- Jennifer BuellExecutive Officer
- Ulf WiinbergDirector
- Ozer BaysalExecutive Officer
- Wadih JordanDirector
- Alex DuncanExecutive Officer
- Christine KlaskinExecutive Officer
- Allison Jeynes-EllisDirector
- Christian CortisExecutive Officer
- Garo H. ArmenExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40MraisedOct 2018 · 2 investors · BiotechnologyRule 506(b)
▶$40MraisedOct 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy R. WrightDirector
- Garo H. ArmenExecutive Officer, Director
- Ozer BaysalExecutive Officer
- Brian CorveseDirector
- Christine KlaskinExecutive Officer
- Ulf WiinbergDirector
- Christian CortisExecutive Officer
- Alex DuncanExecutive Officer
- Evan KearnsExecutive Officer
- Wadih JordanDirector
- Jennifer BuellExecutive Officer
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60MraisedMar 2017 · 1 investors · BiotechnologyRule 506(b)
▶$60MraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen H. ValentineExecutive Officer
- Christine M. KlaskinExecutive Officer
- Shahzad MalikDirector
- Robert B. SteinExecutive Officer
- Garo H. ArmenExecutive Officer, Director
- Timothy WrightDirector
- Ozer BaysalExecutive Officer
- Shalini SharpDirector
- Wadih JordanDirector
- Ulf WiinbergDirector
- Brian CorveseDirector
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJan 2016 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy R. WrightDirector
- Garo ArmenExecutive Officer, Director
- Shalini SharpDirector
- Christine M. KlaskinExecutive Officer
- Charles Evan BallantyneExecutive Officer
- Ozer BaysalExecutive Officer
- Wadih JordanDirector
- Brian CorveseDirector
- Shahzad MalikDirector
- Robert SteinExecutive Officer
- Karen H. ValentineExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedJan 2016 · 17 investors · BiotechnologyRule 506(b)
▶$7.4MraisedJan 2016 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen H. ValentineExecutive Officer
- Timothy R. WrightDirector
- Tom DechaeneDirector
- Shahzad MalikDirector
- Wadih JordanDirector
- Christine M. KlaskinExecutive Officer
- Garo ArmenExecutive Officer, Director
- Brian CorveseDirector
- Charles Evan BallantyneExecutive Officer
- Robert SteinExecutive Officer
- Ozer BaysalExecutive Officer
- Shalini SharpDirector
- Offering amount
- $42.4M
- Amount sold
- $7.4M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedSep 2015 · 2 investors · BiotechnologyRule 506(b)
▶$2.1MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wadih JordanDirector
- Shahzad MalikDirector
- Ozer BaysalExecutive Officer
- Karen H. ValentineExecutive Officer
- Christine M. KlaskinExecutive Officer
- Charles Evan BallantyneExecutive Officer
- Garo H. ArmenExecutive Officer, Director
- Robert SteinExecutive Officer
- Tom DechaeneDirector
- Timothy R. WrightDirector
- Shalini SharpDirector
- Brian CorveseDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.1MraisedMar 2015 · 8 investors · BiotechnologyRule 506(b)
▶$21.1MraisedMar 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tom DechaeneDirector
- Ozer BaysalExecutive Officer
- Wadih JordanDirector
- Garo ArmenExecutive Officer, Director
- Robert SteinExecutive Officer
- Timothy WrightDirector
- Christine KlaskinExecutive Officer
- Shalini SharpDirector
- Karen ValentineExecutive Officer
- Brian CorveseDirector
- Shahzad MalikDirector
- Offering amount
- $21.1M
- Amount sold
- $21.1M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedMar 2015 · 1 investors · BiotechnologyRule 506(b)
▶$35MraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy WrightDirector
- Karen ValentineExecutive Officer
- Ozer BaysalExecutive Officer
- Garo ArmenExecutive Officer, Director
- Shahzad MalikDirector
- Wadih JordanDirector
- Robert SteinExecutive Officer
- Brian CorveseDirector
- Tom DechaeneDirector
- Christine KlaskinExecutive Officer
- Shalini SharpDirector
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.